Analyst Ratings for Amphastar Pharmaceuticals (amph)
amph Rating Summary
amph Price Target Summary
- Highest: $23.00 (Barclays)
- Lowest: $20.00 (Piper Sandler)
- Average: $21.00
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$21.00 (-3.1%)
* Over Last 12-Mos
Rating Score: 1.8 / 10
Percentile Rank: 13%
Avg. $ Target:
$21.00 (-3.1%)
* Over Last 12-Mos
Rating Score: 1.8 / 10
Percentile Rank: 13%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/29/2026 | BofA Securities | Jason Gerberry | Downgrade | Underperform (Neutral) |
20.00 (25.00) |
21.78 (21.68) |
-0.46% | Details |
| 5/14/2026 | Wells Fargo » Updated 8/7/2026 |
Benjamin Burnett | Downgrade | Equal Weight (Overweight) |
20.00 (19.00) |
18.32 (21.68) |
18.34% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
